Literature DB >> 8968549

Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.

D M Hills1, V P Gerskowitch, S P Roberts, N J Welsh, N P Shankley, J W Black.   

Abstract

1. The CCKB/gastrin receptors mediating pentagastrin stimulation of gastric acid secretion by histamine release and by direct stimulation of oxyntic cells have been characterized in the immature rat isolated stomach assay. This was achieved by estimating antagonist affinity values for competitive antagonists from three distinct chemical classes (L-365,260, PD134,308 and JB93190) in the absence and presence of a high concentration of the histamine H2-receptor antagonist, famotidine (30 microM). 2. Pentagastrin produced concentration-dependent stimulation of gastric acid secretion in the absence and presence of famotidine. Famotidine depressed the maximum secretory response to pentagastrin although the degree of depression varied between experimental replicates (25-60%). This variation was attributed to the histamine-release mediated component of acid secretion, as judged by the consistency of the maximum responses obtained in the presence, but not absence, of famotidine. 3. All three CCKB/gastrin receptor antagonists behaved as surmountable antagonists in the absence and presence of famotidine. JB93190 (pKB approximately 9.1, approximately 8.9, in the absence and presence of famotidine, respectively) was approximately 30 fold more potent than either L-365,260 (pKB approximately 7.4, approximately 7.1) or PD134,308 (pKB approximately 7.6, approximately 7.4). 4. It was assumed that the famotidine treatment converted pentagastrin-stimulated acid secretion from a combination of an indirect action due to the release of histamine and a direct action on the oxyntic cell to solely a direct action on the oxyntic cell. A simple mathematical model of this two-receptor system was developed. The direct and indirect components were assumed to sum to produce the total response to pentagastrin obtained in the absence of famotidine. It was found that this model could account quantitatively for the behaviour of the three antagonists without invoking a difference in antagonist affinity for the CCKB/gastrin receptors mediating the direct and indirect actions of pentagastrin. However, a conclusion of receptor homogeneity has to be qualified because the model was also used to generate simulations which indicated that the analysis could only detect antagonist affinity differences of greater than one log-unit between enterochromaffin-like (ECL) and oxyntic cell CCKB/gastrin receptor populations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968549      PMCID: PMC1915833          DOI: 10.1111/j.1476-5381.1996.tb16052.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 2.  Cholecystokinin antagonists.

Authors:  G N Woodruff; J Hughes
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

3.  How we describe competitive antagonists: three questions of usage.

Authors:  D H Jenkinson
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

4.  The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis.

Authors:  J W Black; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

5.  Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach.

Authors:  A K Sandvik; H L Waldum; P M Kleveland; B Schulze Søgnen
Journal:  Scand J Gastroenterol       Date:  1987-09       Impact factor: 2.423

6.  Pharmacological analysis of the pentagastrin-tiotidine interaction in the mouse isolated stomach.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

7.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.

Authors:  V J Lotti; R S Chang
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

8.  Expression cloning and characterization of the canine parietal cell gastrin receptor.

Authors:  A S Kopin; Y M Lee; E W McBride; L J Miller; M Lu; H Y Lin; L F Kolakowski; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay.

Authors:  J A Angus; J W Black; M Stone
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

10.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Authors:  J Hughes; P Boden; B Costall; A Domeney; E Kelly; D C Horwell; J C Hunter; R D Pinnock; G N Woodruff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

View more
  5 in total

1.  Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.

Authors:  E Lindström; M Björkqvist; R Håkanson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach.

Authors:  Maristella Adami; Paolo Frati; Simone Bertini; Anjali Kulkarni-Narla; David R Brown; Giuseppe de Caro; Gabriella Coruzzi; Giulio Soldani
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.

Authors:  Gabriella Coruzzi; Maristella Adami; Elena Guaita; Alessandro Menozzi; Simone Bertini; Elena Giovannini; Giulio Soldani
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

Review 4.  Adenosine: Direct and Indirect Actions on Gastric Acid Secretion.

Authors:  Rosa M Arin; Adriana Gorostidi; Hiart Navarro-Imaz; Yuri Rueda; Olatz Fresnedo; Begoña Ochoa
Journal:  Front Physiol       Date:  2017-09-22       Impact factor: 4.566

Review 5.  The Physiology of the Gastric Parietal Cell.

Authors:  Amy C Engevik; Izumi Kaji; James R Goldenring
Journal:  Physiol Rev       Date:  2019-10-31       Impact factor: 37.312

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.